iScience (Jan 2019)

The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation

  • Maksim V. Baranov,
  • Frans Bianchi,
  • Anastasiya Schirmacher,
  • Melissa A.C. van Aart,
  • Sjors Maassen,
  • Elke M. Muntjewerff,
  • Ilse Dingjan,
  • Martin ter Beest,
  • Martijn Verdoes,
  • Samantha G.L. Keyser,
  • Carolyn R. Bertozzi,
  • Ulf Diederichsen,
  • Geert van den Bogaart

Journal volume & issue
Vol. 11
pp. 160 – 177

Abstract

Read online

Summary: Antigen presentation to T cells in major histocompatibility complex class II (MHC class II) requires the conversion of early endo/phagosomes into lysosomes by a process called maturation. Maturation is driven by the phosphoinositide kinase PIKfyve. Blocking PIKfyve activity by small molecule inhibitors caused a delay in the conversion of phagosomes into lysosomes and in phagosomal acidification, whereas production of reactive oxygen species (ROS) increased. Elevated ROS resulted in reduced activity of cathepsin S and B, but not X, causing a proteolytic defect of MHC class II chaperone invariant chain Ii processing. We developed a novel universal MHC class II presentation assay based on a bio-orthogonal “clickable” antigen and showed that MHC class II presentation was disrupted by the inhibition of PIKfyve, which in turn resulted in reduced activation of CD4+ T cells. Our results demonstrate a key role of PIKfyve in the processing and presentation of antigens, which should be taken into consideration when targeting PIKfyve in autoimmune disease and cancer. : Molecular Mechanism of Gene Regulation; Immunology; Immune Response Subject Areas: Molecular Mechanism of Gene Regulation, Immunology, Immune Response